SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-22-087217
Filing Date
2022-08-08
Accepted
2022-08-08 16:02:41
Documents
5
Period of Report
2022-09-20

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm2222765-1_pre14a.htm PRE 14A 280687
2 GRAPHIC lg_esperionreg-4c.jpg GRAPHIC 40119
3 GRAPHIC sg_benjamin-4c.jpg GRAPHIC 8471
4 GRAPHIC tm2222765d1-px_01pagebw.jpg GRAPHIC 606601
5 GRAPHIC tm2222765d1-px_02pagebw.jpg GRAPHIC 426882
  Complete submission text file 0001104659-22-087217.txt   1771294
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35986 | Film No.: 221144247
SIC: 2834 Pharmaceutical Preparations